Reported 3 months ago
Johnson & Johnson exceeded its Q2 earnings expectations but reduced its 2024 profit forecast. The company's slow medtech sales are influencing its outlook. For more details, watch the full episode of Market Domination for expert analysis and market updates.
Source: YAHOO